Midlands TD Insists Skyclarys Must Be Made Available As Soon As Possible

The Friedreich’s Ataxia treatment was approved by HSE Senior Management last month.

A Longford-Westmeath TD says the October 1st deadline for reimbursement of Skyclarys must be met.

Skyclarys was approved for reimbursement by the HSE Senior Management Team on 25th August for treating patients with the rare genetic condition, Friedreich’s Ataxia.

The product's supplier, Biogen, says stock will be available later this month.

Fine Gael's Micheál Carrigy says he's determind for the rollout to be in place in time for those who need it:

More from Midlands News

Download Our App